Causal effects of fatty acids on atopic dermatitis: A Mendelian randomization study

Area of Science:

• Genetics
• Nutritional Science
• Dermatology

Background:

• Atopic dermatitis (AD) is linked to fatty acid abnormalities, but their causal relationship remains controversial.
• Supplementation with certain fatty acids has shown potential benefits for AD patients.
• Investigating the causal link between fatty acid levels and AD is crucial for understanding disease mechanisms.

Purpose of the Study:

• To determine if fatty acid levels are causally related to atopic dermatitis (AD) using a Mendelian randomization (MR) approach.
• To explore the role of omega-3 (n-3) fatty acids and their specific components, like docosahexaenoic acids (DHA), in AD risk.
• To investigate the underlying genetic mechanisms, particularly involving the FADS gene cluster, in the relationship between fatty acids and AD.

Main Methods:

• Utilized Genome-Wide Association Study (GWAS) data from European ancestry for fatty acid levels and AD.
• Applied Mendelian randomization (MR) methods, including MR Egger and MR-PRESSO, to assess causal inference and identify pleiotropy/heterogeneity.
• Employed Multivariate MR (MVMR) to evaluate the independent causal effect of n-3 fatty acids on AD, controlling for other fatty acids.

Main Results:

• MR analysis indicated that higher n-3 fatty acid levels are associated with a reduced risk of AD (ORIVW: 0.92, 95% CI: 0.87-0.98).
• Specifically, higher docosahexaenoic acids (DHA) levels, a type of n-3 fatty acid, were linked to a lower risk of AD (ORIVW: 0.91, 95% CI: 0.84-0.98).
• Multivariable MR confirmed the robustness of the n-3 fatty acid effect, with no significant pleiotropy or heterogeneity detected. Analyses suggested the FADS gene cluster plays a role in this association.

Conclusions:

• Findings suggest that n-3 fatty acids may play a protective role in reducing the risk of atopic dermatitis (AD).
• Risk prediction tools incorporating n-3 fatty acid levels could enhance AD screening and primary prevention strategies.
• Increasing n-3 fatty acid intake through diet or supplements may be a viable approach for individuals seeking to lower their AD risk.